The world’s leading manufacturer of DNA sequencing systems will pay $9.8 million to resolve allegations that it knowingly ...

Illumina Inc., a leading biotechnology company, has agreed to pay $9.8 million to settle allegations that it sold genomic ...

Illumina allegedly lied about its testing devices meeting government standards Biotech firm Illumina has agreed to cut the US ...

The U.S. alleged the company knowingly sold genetic-sequencing systems with software vulnerabilities to federal agencies.

Image of Cathie Wood via Wikimedia Commons. In a market dominated by headlines about artificial intelligence (AI), cloud ...

Illumina posted revenues of $859m in Q120 - up 1.5% year on year, and bottom-line profits of $173m - a year-on-year decrease of 23%, whilst net profit margins also fell to just over 20%.

SAN DIEGO (AP) — SAN DIEGO (AP) — Illumina Inc. (ILMN) on Thursday reported second-quarter earnings of $235 million. On a per-share basis, the San Diego-based company said it had net income of $1.49.

Illumina Inc., a global leader in DNA sequencing and array-based technologies, today announced that its first product based on its novel Illumina Complete Long Read technology is now available to ...

Illumina Accelerator will collaborate with Helix to support startups building direct-to-consumer genomics products. Illumina Accelerator, which is accepting applications for its seventh funding ...

Given that, more companies can be expected to acquire Illumina sequencers as they work to develop their products. The second piece of good news has to do with revenue potential.

The case is Zirvi v. Illumina Inc, U.S. District Court for the District of New Jersey, No. 2:23-cv-01997. For Monib Zirvi: Joseph Garrity of Lorium Law; and Ahmed Soliman of Soliman & Associates ...

BASEL (Reuters) - Swiss drugmaker Roche Holding AG , bidding $5.7 billion for U.S. gene sequencing company Illumina , pinned its hopes on new products to drive growth this year after reporting a 4 ...